HeadWise HeadWise: Volume 6, Issue 3 | Page 19

testing. Histamine dihydrochloride is a product planned to be used by SC injection. Histamine is a chemical found in some of the body's cells that causes many of the symptoms of allergies, such as a runny nose or sneezing. It is believed to be involved in the pathogenesis of migraine and cluster headaches. Also, in early testing, is the mineral supplement, magnesium L-lactate dehydrate (MLD10) taken daily. Magnesium has been used for several years for migraine prevention. In addition to pharmacological agents, various medical devices are also currently being investigated and evaluated. The vagal nerve is the tenth cranial nerve, supplying the heart, lungs, upper digestive tract, and other organs of the chest and abdomen. A hand-held vagal nerve stimulator as well as transcranial magnetic stimulation are non-invasive options in the pipeline that are currently being used or migraine prevention as well as for acute therapy. Occipital (back of the head) nerve, supraorbital nerve (above the orbit of the eye), and temporo-auricular (pertaining to the temple and the ear) nerve stimulation are also being used but require surgical implantation. These devices are considered, at this time, to be investigational. Similarly, a sphenopalatine ganglion (SPG) (relating to the sphenoid bone at the lower part of the skull and the palate) implantable stimulator is currently being investigated for chronic cluster headache. Could this intervention also, in the future, be considered for prevention of intractable chronic migraine? In addition, an intranasal kinetic oscillation stimulation device is being evaluated for migraine treatment. Conclusions In summary, we have found in the last few years that investigational drugs and devices are being increasingly evaluated for migraine prevention. In my own practice, we are currently involved in the clinical trials of several of these pharmaceutical products and devices. As none of the commercially available agents are effective and tolerable for all migraine patients who need them, any new additions that become commercially available are a